Post-approval studies (Phase 4)Study completedNCT02582255
What this trial is testing
Evaluate the Safety and Immunogenicity of Monovalent OPV2 in Children Aged 1 to 5 Years in Lithuania
Who this might be right for
Poliomyelitis
Fidec Corporation 100